#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14608	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2131	681.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1422	1422	C	879	C	804	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14608	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2131	681.5	0	HET	.	.	.	C226T	.	226	226	C	464	464	C	800	C,T	548,182	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26762	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3463	769.0	0	.	n	.	0	T695C	SNP	695	695	T	1038	1038	C	809	C,T	741,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26762	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3463	769.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	1981	1981	G	841	G,A	551,219	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26762	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3463	769.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2314	2314	C	841	C	776	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26762	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3463	769.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2388	2388	A	856	A	795	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26762	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3463	769.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2940	2940	C	825	C	771	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26762	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3463	769.0	0	HET	.	.	.	C539T,A	.	539	539	C	882	882	C	848	C,T,A	596,181,1	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	138	blaTEM	861	861	100.0	blaTEM.l15.c4.ctg.1	1403	9.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2106	folP	855	855	100.0	folP.l15.c30.ctg.1	1654	127.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1129	1131	AGC	242;245;244	A;G;C,T	222;225;220,1	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5456	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3505	155.1	1	SNP	p	S91F	1	.	.	271	273	TTC	595	597	TTC	222;222;223	T;T;C	208;209;206	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5456	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3505	155.1	1	SNP	p	D95G	1	.	.	283	285	GGC	607	609	GGC	224;223;220	G;G;C,T	204;200;196,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5456	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3505	155.1	1	SNP	p	G95N	0	.	.	283	285	GGC	607	609	GGC	224;223;220	G;G;C,T	204;200;196,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1616	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1264	127.0	1	SNP	p	G45D	0	.	.	133	135	GGC	425	427	GGC	188;187;187	G;G,A;C,A	170;167,1;166,1	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	778	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	945	82.1	0	.	n	.	0	A197.	DEL	197	197	A	564	564	A	187	A	173	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5436	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2901	186.3	1	SNP	p	D86N	0	.	.	256	258	GAC	523	525	GAC	224;221;228	G;A;C	205;199;211	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5436	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2901	186.3	1	SNP	p	S87R	1	.	.	259	261	CGT	526	528	CGT	231;233;233	C;G;T	214;217;215	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5436	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2901	186.3	1	SNP	p	R87I	0	.	.	259	261	CGT	526	528	CGT	231;233;233	C;G;T	214;217;215	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5436	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2901	186.3	1	SNP	p	R87W	0	.	.	259	261	CGT	526	528	CGT	231;233;233	C;G;T	214;217;215	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5436	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2901	186.3	1	SNP	p	S88P	0	.	.	262	264	TCC	529	531	TCC	234;237;239	T;C;C	214;220;221	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4224	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2575	163.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1561	1563	GGC	208;206;205	G;G;C	189;187;187	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4208	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2359	177.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1163	1165	GCA	234;234;233	G;C;A	212;210;215	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4208	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2359	177.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1166	1168	ATC	235;233;235	A;T;C	221;215;217	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4208	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2359	177.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1178	1180	GTG	245;245;244	G;T;G	228;223;224	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4208	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2359	177.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1178	1180	GTG	245;245;244	G;T;G	228;223;224	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4208	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2359	177.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1682	1684	ACC	217;217;223	A;C,T;C	200;201,1;207	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4208	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2359	177.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1736	1738	GCG	227;222;223	G;C;G	195;177;187	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4208	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2359	177.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1736	1738	GCG	227;222;223	G;C;G	195;177;187	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4208	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2359	177.1	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1859	1861	AGC	176;173;175	A,G;G;C,T	156,1;154;157,1	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4208	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2359	177.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1868	1870	GGC	175;175;175	G;G;C	157;155;156	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4208	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2359	177.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1886	1888	CCG	152;154;157	C,CG;C;G	95,1;99;104	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5776	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3082	186.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1622	1624	CCG	218;220;221	C;C;G	187;196;191	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2194	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1760	123.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	502	502	C	154	C,G	133,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2722	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1501	180.4	0	.	p	.	0	N38E	NONSYN	112	114	AAT	424	426	GAA	227;227;224	G;A;A	217;219;214	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2722	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1501	180.4	0	.	p	.	0	N134D	NONSYN	400	402	AAT	712	714	GAT	220;219;219	G;A;T,G	206;203;204,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2722	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1501	180.4	0	.	p	.	0	I138F	NONSYN	412	414	ATC	724	726	TTC	219;220;221	T,A;T;C	203,2;205;207	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2722	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1501	180.4	0	.	p	.	0	P175S	NONSYN	523	525	CCA	835	837	TCA	223;224;229	T;C;A,G	201;200;209,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2722	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1501	180.4	0	.	p	.	0	A218V	NONSYN	652	654	GCC	964	966	GTC	226;224;223	G,A;TCCCC,TCCC;C	205,1;204,1;204	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2722	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1501	180.4	0	.	p	.	0	F222S	NONSYN	664	666	TTT	976	978	TCT	232;231;236	T;C,T;T	209;211,1;217	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2722	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1501	180.4	0	.	p	.	0	A272V	NONSYN	814	816	GCG	1126	1128	GTG	220;220;225	G;T;G	200;201;206	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2722	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1501	180.4	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1294	1296	GCA	230;229;232	G;C,A;A	212;212,1;215	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2722	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1501	180.4	1	SNP	p	G120K	1	.	.	358	360	AAG	670	672	AAG	194;195;197	A,G;A,G;G,T	183,1;180,1;183,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2722	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1501	180.4	1	SNP	p	D121N	0	.	.	361	363	GAC	673	675	GAC	196;199;197	G;A,C;C	183;186,1;185	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2722	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1501	180.4	1	SNP	p	A121D	1	.	.	361	363	GAC	673	675	GAC	196;199;197	G;A,C;C	183;186,1;185	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10568	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4809	218.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1214	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	923	129.9	1	SNP	p	V57M	1	.	.	169	171	ATG	473	475	ATG	260;258;255	A;T;G	243;240;233	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	528	28	tetM	1920	533	99.81	tetM.l15.c30.ctg.1	591	2.1	0	.	p	.	0	M177T	NONSYN	529	531	ATG	587	589	ACG	1;1;1	A;C;G	1;1;1	.	Tetracycline resistance
